The measurement principle of transcutaneous glucose sensors

Sources verified Updated: September 7, 2026 8 min read

The filament of the transcutaneous sensor does not read glucose directly but infers it from a chemical reaction. An enzyme fixed to its tip reacts with the glucose in the interstitial fluid, and at the electrode a very small electric current arises, which the electronics then convert into the figure on the screen.

electrochemical
glucose is turned into a very small electric current
glucose oxidase
the enzyme that makes the sensor specific to glucose
proportional
the current rises with the glucose concentration

How does a transcutaneous sensor measure the blood glucose level?

The transcutaneous sensor has a very thin, flexible filament, much finer than a needle, which is inserted just under the skin, into the fatty tissue. This filament does not sit in a blood vessel but in the fluid between the cells of that tissue, called interstitial fluid. The sensor does not measure directly from the blood but assesses the glucose concentration in this fluid, which closely follows the blood glucose [1].

The measurement is done electrochemically. The sensor converts the glucose concentration into a very small electric current, with the help of an enzyme and an electrode (that thin filament) [2]. The more glucose there is in the interstitial fluid, the larger the current generated locally. The result may lag slightly behind the blood glucose level when that value changes rapidly. The glucose in this fluid synchronizes with the blood values with a small delay [3].

What is the role of the enzyme in the transcutaneous sensor?

The tip of the filament under the skin is covered with an enzyme fixed to its surface, most often glucose oxidase. This enzyme is a biological catalyst, meaning it speeds up the chemical reaction of glucose with oxygen without being consumed in the process [4]. It is the part that actually recognizes the glucose and turns the sensor into an instrument dedicated specifically to glucose, not just a plain general electrode.

The enzyme's main role is to give the sensor specificity, that is, to respond to glucose and largely ignore other substances [5]. This selectivity is not complete, though: with some models, substances such as paracetamol or vitamin C can alter the reading [5]. Without this enzyme, the sensor could not tell glucose apart from the other molecules in the interstitial fluid. Some older sensors use a related enzyme, glucose dehydrogenase, but the measurement principle remains the same [5] [6].

How does the transcutaneous sensor turn glucose into a signal?

The enzyme (glucose oxidase) makes the glucose react with the oxygen in the interstitial fluid. This reaction produces gluconic acid and hydrogen peroxide (H₂O₂). The amount of hydrogen peroxide produced is directly proportional to the glucose concentration, that is, more glucose means more hydrogen peroxide [4].

The hydrogen peroxide reaches the sensor's electrode, where it breaks down and releases electrons, which form a very weak electric current. This current is essentially the signal picked up by the sensor, and its magnitude reflects the glucose concentration in the interstitial fluid, as the figure below shows [5].

Figure 1

How the sensor estimates glucose

  1. Step 1The enzyme meets the glucoseGlucose oxidase at the tip of the filament makes glucose react with oxygen, in the fluid between the cells.
  2. Step 2Hydrogen peroxide appearsThe amount produced is directly proportional to the glucose concentration. More glucose means more hydrogen peroxide.
  3. Step 3The electrode picks up a currentAt the electrode the hydrogen peroxide breaks down and releases electrons, which form a very weak electric current.
  4. Step 4The current becomes a valueThe device turns the size of the current into the glucose value you see on the screen.
The measurement is electrochemical, not optical. The sensor does not see the glucose, it turns it into an electric current [2]. The more glucose there is in the fluid between the cells, the larger the current generated locally [5]. The reaction uses up a negligible amount of glucose, so the sensor does not lower your glucose.

Does the reaction in the transcutaneous sensor consume glucose?

Yes, the reaction consumes a very small amount of glucose. Each glucose molecule that reacts with the local oxygen turns into gluconic acid, so it is used up on the spot. The enzyme attached to the filament is covered by a special membrane. This membrane lets only a small, controlled amount of glucose through, so the reaction stays limited: its rate is set by the membrane, not by the amount of glucose around it [7].

This consumed amount is small enough not to lower the blood glucose or deplete the glucose around the filament, so the later readings are not affected either. The body continuously replenishes the glucose in the interstitial fluid from the glucose in the blood. The enzyme is a catalyst and is not consumed, but over time both it and the membrane can wear out, which is why the sensor has a limited lifespan [8].

How does the transcutaneous sensor's signal become a displayed value?

What you see as a simple filament under the skin actually contains several electrodes, arranged in very thin layers and insulated from one another on the same flexible support. Each electrode has its own role:

  • the working electrode is coated with enzyme and produces the signal;
  • the reference electrode holds a stable voltage, used as a reference point;
  • the counter (auxiliary) electrode closes the electrical circuit [6].

The electronic component attached to the sensor keeps a constant voltage between the working electrode and the reference electrode. The chemical reaction does not change this voltage, only the strength of the current. The higher the glucose concentration in the interstitial fluid, the greater the strength of the current passing through the working electrode.

Some systems add a fourth electrode, without enzyme, which measures the background noise, that is, the small signal present even when there is no glucose. The signal from this electrode is subtracted from the useful signal, in order to reduce the influence of other substances.

The measured current is read continuously by the electronic component (transmitter). A calibration factor converts this current into an estimated glucose value [2]. Many modern sensors are factory-calibrated, while others occasionally need a check and possibly a recalibration with the glucometer [9]. The system's algorithms, meaning the programs that run in the transmitter or in the phone app, smooth the small electrical variations and partly correct the delay between the interstitial fluid and the blood [3]. The result is expressed in mg/dL or mmol/L and sent wirelessly to a phone or another receiver.

Does the transcutaneous sensor need power to work?

Yes, the sensor needs a small source of power, usually a battery housed in the transmitter. This power maintains a constant electric potential on the electrode, and the chemical reaction catalyzed by glucose oxidase generates a current proportional to the glucose concentration [6]. It also powers the signal processing, the internal memory and the wireless sending of the data to the phone or receiver [10].

Power consumption is very low, so a tiny battery is enough for the whole time you wear the sensor. Most continuous monitoring systems work for between 7 and 15 days (recently even 21 days) [11] [12]. After this interval the sensor is replaced with a new one, together with its power source. On older models the transmitter is reused across several sensors [10].

Conclusions

  • The sensor's filament sits in the interstitial fluid under the skin, not in a blood vessel, and the measurement is done electrochemically [1] [2].
  • The enzyme fixed to the tip of the filament, most often glucose oxidase, is a catalyst that is not consumed and that gives the sensor specificity for glucose [4] [5].
  • The glucose reacts with the oxygen and produces hydrogen peroxide, which at the electrode releases electrons, and the resulting current is proportional to the glucose concentration [4] [5].
  • A calibration factor converts the current into an estimated glucose value, and the internal software smooths the signal and partly corrects the delay relative to the blood [2] [3].
  • A tiny battery in the transmitter maintains the electrode's potential and sends the data wirelessly, for the 7–15 days a sensor usually lasts [10] [11].

You might also be interested in

Other pages about the basics of glucose sensor technology.

Glossary terms used here

References

  1. Ionescu-Tîrgoviște C, Guja C, Ioacara S, Dumitrescu D, Tomescu I. Continuous glucose monitoring: physiologic and pathophysiologic significance. Rom J Intern Med. 2004;42(2):381-393. PubMed
  2. Acciaroli G, Vettoretti M, Facchinetti A, Sparacino G. Calibration of Minimally Invasive Continuous Glucose Monitoring Sensors: State-of-The-Art and Current Perspectives. Biosensors (Basel). 2018;8(1):24. PubMed
  3. Keenan DB, Mastrototaro JJ, Voskanyan G, Steil GM. Delays in minimally invasive continuous glucose monitoring devices: a review of current technology. J Diabetes Sci Technol. 2009;3(5):1207-1214. PubMed
  4. Bankar SB, Bule MV, Singhal RS, Ananthanarayan L. Glucose oxidase--an overview. Biotechnol Adv. 2009;27(4):489-501. PubMed
  5. Hassan MH, Vyas C, Grieve B, Bartolo P. Recent Advances in Enzymatic and Non-Enzymatic Electrochemical Glucose Sensing. Sensors (Basel). 2021;21(14):4672. PubMed
  6. Heller A, Feldman B. Electrochemistry in diabetes management. Acc Chem Res. 2010;43(7):963-973. PubMed
  7. Wu M, Li L, Yu R, Zhang Z, Zhu B, Lin J, et al. Tailored diffusion limiting membrane for microneedle glucose sensors with wide linear range. Talanta. 2024;273:125933. PubMed
  8. Vaddiraju S, Burgess DJ, Tomazos I, Jain FC, Papadimitrakopoulos F. Technologies for continuous glucose monitoring: current problems and future promises. J Diabetes Sci Technol. 2010;4(6):1540-1562. PubMed
  9. American Diabetes Association Professional Practice Committee. 7. Diabetes Technology: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Suppl 1):S150-S165. PubMed
  10. Cappon G, Vettoretti M, Sparacino G, Facchinetti A. Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications. Diabetes Metab J. 2019;43(4):383-397. PubMed
  11. Bhargava A, McKeating KS, Lin A, Chen T. Accuracy and Reliability of the Sinocare Continuous Glucose Monitoring System. Diabetes Ther. 2025;16(9):1861-1870. PubMed
  12. Forlenza GP, Deshpande S, Ly TT, Howsmon DP, Cameron F, Baysal N, et al. Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial. Diabetes Care. 2017;40(8):1096-1102. PubMed